Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis
Chiung‐Kuei Huang, Soo Ok Lee, Kuo‐Pao Lai, Wen‐Lung Ma, Tzu‐Hua Lin, Meng‐Yin Tsai, Jie Luo, Chawnshang Chang – 13 November 2012 – Transplantation of bone marrow mesenchymal stem cells (BM‐MSCs) has been considered as an alternative therapy, replacing liver transplantation in clinical trials, to treat liver cirrhosis, an irreversible disease that may eventually lead to liver cancer development. However, low survival rate of the BM‐MSCs leading to unsatisfactory efficacy remains a major concern.